|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.00 THB | 0.00% |
|
-3.55% | +1.49% |
| Market Cap | 29.64B 911M 786M 723M 678M 1.27B 86.13B 1.29B 8.55B 3.34B 42.18B 3.42B 3.35B 146B | P/E Ratio 2026 * |
12.8x | P/E Ratio 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 24.79B 762M 657M 605M 567M 1.07B 72.03B 1.08B 7.15B 2.79B 35.28B 2.86B 2.8B 122B | EV / Sales 2026 * |
1.67x | EV / Sales 2027 * | 1.59x |
| Free-Float |
38.61% | Yield 2026 * |
5.22% | Yield 2027 * | 5.52% |
Last Transcript: Mega Lifesciences
| 1 week | -3.55% | ||
| Current month | -5.56% | ||
| 1 month | -2.86% | ||
| 6 months | +3.03% | ||
| Current year | +1.49% |
| 1 week | 33.75 |  | 35.25 |
| 1 month | 33.75 | | 36 |
| Current year | 31.5 | | 40 |
| 1 year | 24.6 | | 40 |
| 3 years | 24.3 | | 46.75 |
| 5 years | 24.3 | | 56.5 |
| 10 years | 15.9 | | 56.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vivek Dhawan
CEO | Chief Executive Officer | 64 | 01/01/1988 |
Thomas Abraham
DFI | Director of Finance/CFO | 61 | 01/01/1997 |
Jonnara Reddy
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Abraham
BRD | Director/Board Member | 61 | 01/01/1998 |
Vivek Dhawan
BRD | Director/Board Member | 64 | 01/01/2013 |
Thor Santhisiri
BRD | Director/Board Member | 73 | 01/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.55% | - | - | 911M | |
| -0.32% | -1.72% | +37.83% | +148.79% | 1,007B | |
| -2.16% | +1.51% | +50.01% | +43.93% | 567B | |
| -2.70% | -0.66% | +15.97% | +63.07% | 392B | |
| -0.29% | +1.05% | +20.91% | +18.37% | 328B | |
| -0.35% | +1.18% | +24.29% | +31.97% | 277B | |
| +0.53% | -2.68% | +22.63% | +12.54% | 275B | |
| -0.45% | +5.42% | -42.96% | -48.52% | 196B | |
| -1.31% | +1.39% | +18.74% | +53.45% | 189B | |
| -1.03% | -2.97% | +13.02% | +57.34% | 154B | |
| Average | -0.09% | +0.33% | +17.83% | +42.33% | 376.23B | |
| Weighted average by Cap. | +0.11% | -0.03% | +26.48% | +67.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.88B 457M 394M 363M 340M 639M 43.23B 646M 4.29B 1.68B 21.17B 1.72B 1.68B 73.25B | 15.61B 480M 414M 381M 357M 671M 45.36B 678M 4.5B 1.76B 22.21B 1.8B 1.76B 76.87B |
| Net income | 2.32B 71.33M 61.48M 56.58M 53.08M 99.7M 6.74B 101M 669M 261M 3.3B 268M 262M 11.42B | 2.46B 75.63M 65.19M 59.99M 56.28M 106M 7.15B 107M 709M 277M 3.5B 284M 278M 12.11B |
| Net Debt | -4.85B -149M -129M -118M -111M -209M -14.1B -211M -1.4B -546M -6.9B -560M -548M -23.89B | -4.76B -146M -126M -116M -109M -204M -13.82B -206M -1.37B -536M -6.77B -549M -537M -23.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 34.00 ฿ | 0.00% | 872,900 |
| 12/06/26 | 34.00 ฿ | -0.73% | 2,332,900 |
| 11/06/26 | 34.25 ฿ | -0.72% | 951,100 |
| 10/06/26 | 34.50 ฿ | -2.13% | 1,369,400 |
| 09/06/26 | 35.25 ฿ | 0.00% | 408,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEGA Stock
- MEGA-R Stock
Select your edition
All financial news and data tailored to specific country editions
